Cochlear Ebitda from 2010 to 2026

OC5 Stock  EUR 118.92  1.08  0.90%   
Cochlear's EBITDA is increasing over the last several years with slightly volatile swings. EBITDA is predicted to flatten to about 332.4 M. During the period from 2010 to 2026 Cochlear Limited EBITDA regressed destribution of quarterly values had mean deviationof  97,245,152 and mean square error of 30061.8 T. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
559.9 M
Current Value
332.4 M
Quarterly Volatility
176.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Cochlear financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cochlear's main balance sheet or income statement drivers, such as Tax Provision of 87.9 M, Net Interest Income of 845.2 K or Interest Income of 14.1 M, as well as many indicators such as . Cochlear financial statements analysis is a perfect complement when working with Cochlear Valuation or Volatility modules.
  
This module can also supplement various Cochlear Technical models . Check out the analysis of Cochlear Correlation against competitors.
The Ebitda trend for Cochlear Limited offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Cochlear is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Cochlear's Ebitda Growth Pattern

Below is the plot of the Ebitda of Cochlear Limited over the last few years. It is Cochlear's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cochlear's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Cochlear Ebitda Regression Statistics

Arithmetic Mean345,868,901
Coefficient Of Variation51.01
Mean Deviation97,245,152
Median332,442,315
Standard Deviation176,423,525
Sample Variance31125.3T
Range820.5M
R-Value0.31
Mean Square Error30061.8T
R-Squared0.09
Significance0.23
Slope10,741,700
Total Sum of Squares498004.2T

Cochlear Ebitda History

2026332.4 M
2025559.9 M
2022486.9 M
2021475.4 M
2020377.7 M
2019-260.6 M
2018370.8 M

About Cochlear Financial Statements

Cochlear stakeholders use historical fundamental indicators, such as Cochlear's Ebitda, to determine how well the company is positioned to perform in the future. Although Cochlear investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cochlear's assets and liabilities are reflected in the revenues and expenses on Cochlear's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cochlear Limited. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA559.9 M332.4 M

Currently Active Assets on Macroaxis

Other Information on Investing in Cochlear Stock

Cochlear financial ratios help investors to determine whether Cochlear Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cochlear with respect to the benefits of owning Cochlear security.